Conduit Pharmaceuticals Inc. announced that it presented a compliance plan to Nasdaq regarding its listing rules, specifically seeking an extension to comply with minimum bid price and market value ...
Conduit Pharmaceuticals Inc., currently valued at $1.28 million and showing a weak financial health score according to InvestingPro analysis, has been granted an extension by The Nasdaq Stock Market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results